NeoPharm CO., LTD. (092730.KQ)

KRW 11960.0

(-0.33%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 179.33 Billion 155.34 Billion 143.4 Billion 132.97 Billion 122.74 Billion 72.92 Billion
Total Current Assets 135.49 Billion 131.27 Billion 121.48 Billion 113.55 Billion 101.68 Billion 58.93 Billion
Cash And Short Term Investments 111.99 Billion 113.48 Billion 105.04 Billion 96.18 Billion 85.51 Billion 42.42 Billion
Cash and Cash Equivalents 11.88 Billion 10.88 Billion 7.04 Billion 11.18 Billion 5.51 Billion 8.42 Billion
Short Term Investments 100.1 Billion 102.6 Billion 98 Billion 84.99 Billion 80 Billion 34 Billion
Net Receivables 10.63 Billion 7.66 Billion 8.04 Billion 8.86 Billion 9.62 Billion 9.18 Billion
Inventory 10.19 Billion 8.74 Billion 7.97 Billion 8.08 Billion 5.84 Billion 6.84 Billion
Other Current Assets 2.67 Billion 1.37 Billion 416.16 Million 418.14 Million 698.55 Million 488.05 Million
Total Non-Current Assets 43.83 Billion 24.07 Billion 21.92 Billion 19.42 Billion 21.06 Billion 13.99 Billion
Net PPE 29.24 Billion 9.34 Billion 9.74 Billion 10.12 Billion 10.49 Billion 10.44 Billion
Good Will And Intangible Assets 2.23 Billion 1.78 Billion 2.05 Billion 2.38 Billion 2.38 Billion 1.17 Billion
Good Will - - - - - -
Intangible Assets 2.23 Billion 1.78 Billion 2.05 Billion 2.38 Billion 2.38 Billion 1.17 Billion
Long-Term Investments 10.45 Billion 12.17 Billion 9.3 Billion 6.1 Billion 7.12 Billion 1.73 Billion
Tax Assets 1.31 Billion 135.31 Million 171.2 Million 375.55 Million 595.82 Million 181.23 Million
Other Non Current Assets 583.69 Million 637.83 Million 646.4 Million 442.5 Million 462.01 Million 462.01 Million
Other Assets - 1.00 1.00 - - 1.00
Total Liabilities 19.3 Billion 13.13 Billion 13.1 Billion 15.26 Billion 17.04 Billion 13.64 Billion
Total Current Liabilities 17.61 Billion 13.13 Billion 12.94 Billion 14.87 Billion 12.83 Billion 12.89 Billion
Account Payables 6.43 Billion 3.7 Billion 4.34 Billion 4.19 Billion 3.17 Billion 3.46 Billion
Tax Payables 4.54 Billion 3.77 Billion 3.14 Billion 2.29 Billion 2.59 Billion 3.23 Billion
Short Term Debt 617.57 Million 393.57 Million 437.7 Million 4.27 Billion 656.34 Million 30.94 Million
Deferred Revenue 230.65 Million 567.28 Million 584.83 Million 325.91 Million 283.79 Million 314.6 Million
Other Current Liabilities 10.33 Billion 8.47 Billion 7.57 Billion 6.08 Billion 8.71 Billion 9.08 Billion
Total Non Current Liabilities 1.69 Billion - 162.33 Million 383.61 Million 4.21 Billion 747.11 Million
Long-Term Debt 430.04 Million - 101.79 Million 19.36 Million 4 Billion 400 Million
Deferred Revenue Non Current 92.00 - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 57.73 Million - 60.54 Million 364.24 Million 217.81 Million 347.11 Million
Other Liabilities 1.00 - - - - 1.00
Total Equity 160.02 Billion 142.21 Billion 130.3 Billion 117.71 Billion 105.69 Billion 59.28 Billion
Stock Holders Equity 160.02 Billion 142.21 Billion 130.3 Billion 117.71 Billion 105.69 Billion 59.28 Billion
Common Stock 4.1 Billion 4.1 Billion 4.1 Billion 4.1 Billion 4.1 Billion 3.73 Billion
Retained Earnings 109.53 Billion 92.58 Billion 80.87 Billion 68.63 Billion 57.2 Billion 43.33 Billion
Accumulated other comprehensive income 4.44 Billion 3.58 Billion 2.83 Billion 3.03 Billion 2.44 Billion 1.87 Billion
Common Stock Equity 160.02 Billion 142.21 Billion 130.3 Billion 117.71 Billion 105.69 Billion 59.28 Billion
Capital Lease Obligation 430.04 Million 393.57 Million 101.79 Million 19.36 Million 256.34 Million -
Total Investments 110.56 Billion 114.77 Billion 107.3 Billion 91.09 Billion 87.12 Billion 35.73 Billion
Total Debt 1.04 Billion 393.57 Million 539.5 Million 4.29 Billion 4.65 Billion 400 Million
Net Debt -10.83 Billion -10.48 Billion -6.5 Billion -6.89 Billion -858.91 Million -8.02 Billion

Balance Sheet Charts